GENOMIC & PRECISION MEDICINE (1).pptx
•Download as PPTX, PDF•
0 likes•27 views
This document discusses genomics and precision medicine. It provides an overview of genomic testing and its uses in precision medicine for diagnosis, treatment decisions, and predicting disease risk and drug response. Examples are given of how genomic sequencing helped diagnose and treat two children misdiagnosed with cerebral palsy. The document also describes the genomic facilities and research at the University of Indonesia, including labs for PCR, sequencing, and product development like a portable PCR device for genomic research. It emphasizes the importance of multi-disciplinary collaboration and applying artificial intelligence in genomic learning.
Report
Share
Report
Share
Recommended
iCAAD London 2019 - Antonio Metastasio - PERSONALISED MEDICINE IN THE TREATM...
Personalised medicine is considered the next frontier of health care. The role of genetic testing in psychiatry and in addictions medicine, however, has been recently critically reviewed. Are genetic tests helpful in assessing and managing these conditions?
Personalized medicine
Personalized medicine are medicine which are made according to different genetic makeup of an individual
"Hacking the Software for Life" - Brad Perkins (Chief Medical Officer, Human ...
"Hacking the Software for Life" - Brad Perkins (Chief Medical Officer, Human Logevity, Inc.)
Delivered at the inaugural Hyper Wellbeing Summit, 14th November 2016, Mountain View, California.
For more information including details of subsequent events, please visit http://hyperwellbeing.com
The summit was created to foster a community around an emerging industry - Wellness as a Service (WaaS). Consumer technologies, in particular wearables and mobile, are powering a consumer revolution. A revolution to turn health and wellness into platform delivered services. A revolution enabling consumer data-driven disease risk reduction. A revolution extending health care past sick care towards consumer-led lifelong health, wellness and lifestyle optimization.
WaaS newsletter sign-up http://eepurl.com/b71fdr
@hyperwellbeing
Genomics: The coming challenge to the health system
AHIA 2011 Conference presentation by Prof Warwick Anderson, National health and Medical Research Centre
molecular biology pharmacogenomics and SNPs
Trade-offs involve losing one quality or aspect in return for gaining another. Polymorphism refers to appearing in different forms. Single nucleotide polymorphisms (SNPs) are variations where a single DNA nucleotide differs between individuals. SNPs occur frequently and make each person genetically unique. They can influence disease susceptibility and drug response. Pharmacogenomics studies how genetic variations affect individual responses to drugs and is important for personalized medicine. It aims to optimize drug therapy based on a person's genetic makeup.
molecular biology pharmacogenomics and SNPs
Trade-offs involve losing one quality or aspect in return for gaining another. Polymorphism refers to appearing in different forms. Single nucleotide polymorphisms (SNPs) are variations where a single DNA nucleotide differs between individuals. SNPs occur frequently and make each person genetically unique. They can influence disease susceptibility and drug response. Pharmacogenomics studies how genetic variations affect individual responses to drugs and is important for personalized medicine.
Exploring the neuroblastoma epigenome: perspectives for improved prognosis
EXPLORING THE NEUROBLASTOMA EPIGENOME: PERSPECTIVES FOR THE DISCOVERY OF PROGNOSISTIC BIOMARKERS
M. Ongenaert, A. Decock, J. Vandesompele, F. Speleman
Center for Medical Genetics, Ghent University, Ghent, Belgium (mate.ongenaert@ugent.be)
Neuroblastoma (NB) is a childhood tumor originating from sympathetic nervous system cells. Although recently new insights into genes involved in NB have emerged, the molecular basis of neuroblastoma development and progression still remains poorly understood. The best-characterized genetic alterations include amplification of the proto-oncogene MYCN, ALK activating mutations or amplification, gain of chromosome arm 17q and losses of 1p, 3p, and 11q. Epigenetic alterations have been described as well: caspase-8 (CASP8) and RAS-association domain family 1 isoform A (RASSF1A) DNA-methylation are important events for the development and progression of neuroblastoma. In total, there are about 75 genes described as epigenetically affected in NB cell lines and/or NB primary samples.
Most of these methylation markers are found using ‘candidate gene’ approaches and the methylation frequencies are usually very low. In order to find novel methylation markers that can be used for improved prognosis, we applied a whole-genome methylation screen. This technique relies on capturing with the MBD2 protein, containing a methyl-binding domain (MBD), with a very high affinity towards methylated genomic regions. In an initial phase, MBD2-seq was performed on 8 NB cell lines (where we also had micro-array data of, before and after treatment with DAC). As these results are promising, we will explore the complete methylomes of 45 primary NB tumors.
Based on an integrative analysis (re-expression results, expression micro-arrays, MBD2-sequencing on cell lines), 48 MSP (Methylation Specific PCR) assays were tested on 89 primary neuroblastoma patients of different risk categories. The results of this validation study demonstrate the power of epigenetic biomarkers as several assays are informative for prognosis and survival.
Bea lehming memorial lectures cacs - washington dc 11-15-2014
Drs. Sue and Thomas O'Dorosio Presentation
Carcinoid / Neuroendocrine Tumor Cancer Presentation
to
Capitol Area Carcinoid /NETs Survivors Group
Recommended
iCAAD London 2019 - Antonio Metastasio - PERSONALISED MEDICINE IN THE TREATM...
Personalised medicine is considered the next frontier of health care. The role of genetic testing in psychiatry and in addictions medicine, however, has been recently critically reviewed. Are genetic tests helpful in assessing and managing these conditions?
Personalized medicine
Personalized medicine are medicine which are made according to different genetic makeup of an individual
"Hacking the Software for Life" - Brad Perkins (Chief Medical Officer, Human ...
"Hacking the Software for Life" - Brad Perkins (Chief Medical Officer, Human Logevity, Inc.)
Delivered at the inaugural Hyper Wellbeing Summit, 14th November 2016, Mountain View, California.
For more information including details of subsequent events, please visit http://hyperwellbeing.com
The summit was created to foster a community around an emerging industry - Wellness as a Service (WaaS). Consumer technologies, in particular wearables and mobile, are powering a consumer revolution. A revolution to turn health and wellness into platform delivered services. A revolution enabling consumer data-driven disease risk reduction. A revolution extending health care past sick care towards consumer-led lifelong health, wellness and lifestyle optimization.
WaaS newsletter sign-up http://eepurl.com/b71fdr
@hyperwellbeing
Genomics: The coming challenge to the health system
AHIA 2011 Conference presentation by Prof Warwick Anderson, National health and Medical Research Centre
molecular biology pharmacogenomics and SNPs
Trade-offs involve losing one quality or aspect in return for gaining another. Polymorphism refers to appearing in different forms. Single nucleotide polymorphisms (SNPs) are variations where a single DNA nucleotide differs between individuals. SNPs occur frequently and make each person genetically unique. They can influence disease susceptibility and drug response. Pharmacogenomics studies how genetic variations affect individual responses to drugs and is important for personalized medicine. It aims to optimize drug therapy based on a person's genetic makeup.
molecular biology pharmacogenomics and SNPs
Trade-offs involve losing one quality or aspect in return for gaining another. Polymorphism refers to appearing in different forms. Single nucleotide polymorphisms (SNPs) are variations where a single DNA nucleotide differs between individuals. SNPs occur frequently and make each person genetically unique. They can influence disease susceptibility and drug response. Pharmacogenomics studies how genetic variations affect individual responses to drugs and is important for personalized medicine.
Exploring the neuroblastoma epigenome: perspectives for improved prognosis
EXPLORING THE NEUROBLASTOMA EPIGENOME: PERSPECTIVES FOR THE DISCOVERY OF PROGNOSISTIC BIOMARKERS
M. Ongenaert, A. Decock, J. Vandesompele, F. Speleman
Center for Medical Genetics, Ghent University, Ghent, Belgium (mate.ongenaert@ugent.be)
Neuroblastoma (NB) is a childhood tumor originating from sympathetic nervous system cells. Although recently new insights into genes involved in NB have emerged, the molecular basis of neuroblastoma development and progression still remains poorly understood. The best-characterized genetic alterations include amplification of the proto-oncogene MYCN, ALK activating mutations or amplification, gain of chromosome arm 17q and losses of 1p, 3p, and 11q. Epigenetic alterations have been described as well: caspase-8 (CASP8) and RAS-association domain family 1 isoform A (RASSF1A) DNA-methylation are important events for the development and progression of neuroblastoma. In total, there are about 75 genes described as epigenetically affected in NB cell lines and/or NB primary samples.
Most of these methylation markers are found using ‘candidate gene’ approaches and the methylation frequencies are usually very low. In order to find novel methylation markers that can be used for improved prognosis, we applied a whole-genome methylation screen. This technique relies on capturing with the MBD2 protein, containing a methyl-binding domain (MBD), with a very high affinity towards methylated genomic regions. In an initial phase, MBD2-seq was performed on 8 NB cell lines (where we also had micro-array data of, before and after treatment with DAC). As these results are promising, we will explore the complete methylomes of 45 primary NB tumors.
Based on an integrative analysis (re-expression results, expression micro-arrays, MBD2-sequencing on cell lines), 48 MSP (Methylation Specific PCR) assays were tested on 89 primary neuroblastoma patients of different risk categories. The results of this validation study demonstrate the power of epigenetic biomarkers as several assays are informative for prognosis and survival.
Bea lehming memorial lectures cacs - washington dc 11-15-2014
Drs. Sue and Thomas O'Dorosio Presentation
Carcinoid / Neuroendocrine Tumor Cancer Presentation
to
Capitol Area Carcinoid /NETs Survivors Group
Gene therapy
This document summarizes the history and development of gene therapy from the 1950s to the present. It discusses key events like the isolation of genes in the 1970s and 1980s and the first human gene therapy treatment in 1990. It outlines various gene therapy strategies like ex vivo and in vivo approaches and delivery methods like viruses, liposomes, microinjection, and electroporation. Challenges of gene therapy are also summarized like ethical issues, high costs, and ensuring safety. The document aims to provide an overview of the progress of gene therapy and remaining barriers to its clinical application and acceptance.
Socrate
The document outlines a strategy to improve translational research and clinical trials through more tailored and personalized approaches. It proposes combining basic research on topics like DNA repair mechanisms with biology-driven therapies and immunotherapies guided by a patient's specific biomarkers. The goal is to move beyond one-size-fits-all approaches to cancer treatment and instead target therapies based on a patient's individual cancer biology and vulnerabilities to achieve better outcomes.
Solutions for Personalized Medicine brochure
The document discusses personalized medicine and describes some of the tools and technologies used for biomarker discovery and validation to enable personalized medicine. Specifically, it discusses:
1) Affymetrix provides a portfolio of tools to detect and validate DNA and RNA biomarkers for diseases like cancer through microarrays, services, and assays that can interrogate genomes, transcriptomes, genes, pathways, and individual molecules.
2) RNA and DNA biomarkers like gene expressions levels, mutations, and other genomic alterations can serve as indicators of disease processes and therapeutic responses. Affymetrix tools allow analysis of whole genomes, transcriptomes, alternative splicing, and single-cell analysis.
3) These tools are used to discover and validate biomarkers which
Concept of genomics, proteomics and metabolomics
Dr. M. N. Astagimath's presentation discusses genomics, proteomics, and metabolomics. The objectives are to understand the concepts and define each term. Genomics is the study of genomes and involves functional, structural, and epigenomics. Proteomics is the large-scale study of proteins and involves expression, interaction, and biomarker analysis. Metabolomics is the study of small molecule metabolites and their profiles can provide unique fingerprints of cellular processes. A variety of methods are used in each field like sequencing and mass spectrometry. The data has applications in medicine such as diagnosis, risk assessment, and bioengineering.
Genomics
This document summarizes a seminar on genomics presented by Komal Rajgire. It defines genomics as the study of all genes in an organism, including their mapping, sequencing, and functional analysis. The key differences between genetics and genomics are outlined. The document discusses approaches in functional genomics like homology searching and expression analysis. It also covers related fields like structural genomics, epigenomics, metagenomics, pharmacogenomics, and the applications and future impact of genomics on medicine, drug discovery, and personalized treatment.
SCREENING WHAT TESTS WHEN & WHAT NEXT?
This document provides guidance on prenatal screening tests and what they can detect. It discusses the principles of screening and outlines various first and second trimester screening options for detecting chromosomal abnormalities, structural defects, and conditions like preeclampsia. Diagnostic tests mentioned include karyotyping, FISH, QF-PCR, microarrays, and their abilities to identify abnormalities like trisomies, deletions, and duplications. Low-dose aspirin is noted as an intervention for preeclampsia in high-risk patients.
ENT Presentation
This document discusses next generation sequencing to identify bacteria, fungi, and viruses from patient samples. It summarizes discussions and presentations from several ear, nose, and throat doctors and researchers on using DNA sequencing to diagnose biofilm infections. DNA sequencing was able to identify more pathogens than traditional cultures and provided faster results. Identifying biofilms is important as they are resistant to antibiotics and cause chronic infections. The document promotes using a molecular diagnostic test from PathoGenius to identify pathogens in patient samples, which it says provides faster, more comprehensive results than cultures and is covered by Medicare.
Pharmacogenomics
Pharmacogenomics is the study of how genetic factors influence individual responses to drugs. It aims to develop personalized drug therapies tailored to an individual's genetics. This could increase drug effectiveness to nearly 100% while decreasing side effects significantly by identifying genetic reasons for variances in drug response. However, barriers remain such as complexity in finding gene variations and limited drug alternatives. Overall, pharmacogenomics promises more rational drug development and safer, more accurate individualized treatment but overcoming challenges will require multidisciplinary efforts.
Diagnosis of cancer
diagnosis of cancer, bioluminescent detection, diagnosis of cancer, haplotype mapping, imaging gene expression in vivo, types of cancer diagnosis method, ultrasound imaging
Genetic screening & gene therapy
Genetic screening and gene therapy can detect and treat genetic disorders. Genetic screening techniques like carrier screening, newborn screening, and prenatal diagnosis identify genetic risks. Gene therapy aims to treat diseases by replacing faulty genes, such as inserting functional genes into somatic cells. While promising, gene therapy faces challenges like safety concerns over viral vectors and ensuring proper expression of inserted genes. Genetic counseling educates patients on genetic risks and testing options.
Applied Genetic (Genetika Terapan) - Chaidir Adam 2018
Applied Genetic
- Medical Genetic
- DNA Fingerprinting & Forensic Analysis
- PCR, RFLP, Electrophoresis
- Human Genome Project
Genomics
Genomics is the study of genomes, which are the complete set of genetic material within an organism. It has emerged through public funding and collaboration between academic and private research. There are two main eras - the genomic era focused on genome sequencing, while the current post-genomic era analyzes gene functions and regulation. Types of genomics include cognitive, comparative, functional, and personal genomics. It has various applications like drug discovery, conservation efforts, and understanding disease and human variation.
Multi Omics Approach in Medicine
This document discusses multi-omics approaches in medicine. It begins by describing traditional Oslerian and systems approaches to defining disease. It then introduces omics technologies and precision medicine. The main body discusses different omics approaches including genomics, epigenomics, transcriptomics, proteomics, metabolomics, and microbiomics. For each approach, it covers concepts, applications, and challenges. It emphasizes how multi-omics integration can provide a more comprehensive understanding of disease and inform precision medicine.
Gene rx [autosaved]
Gene therapy involves introducing genetic material into cells to treat or prevent disease. It has the potential to cure genetic disorders by correcting the underlying genetic defect. There are two main types - somatic gene therapy, which affects only targeted cells and is safer, and germline gene therapy which can permanently alter the genes and be passed to offspring. Recent advances include FDA-approved CAR-T immunotherapies for cancer and the first gene therapy approved for an inherited retinal disease. Challenges remain regarding delivery methods, safety, and ethical issues.
Cell Therapy Expansion and Challenges in Autoimmune Disease
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Top-Vitamin-Supplement-Brands-in-India List
Swisschem Dermacare provides the Top 10 Vitamin Supplement Brands in India. To know more about us give us call at our official number
Light House Retreats: Plant Medicine Retreat Europe
Our aim is to organise conscious gatherings and retreats for open and inquisitive minds and souls, with and without the assistance of sacred plants.
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Learn about body grief and ways to cope with it. We will also explore methods to heal from this challenging experience.
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Role of Mukta Pishti in the Management of Hyperthyroidism
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
More Related Content
Similar to GENOMIC & PRECISION MEDICINE (1).pptx
Gene therapy
This document summarizes the history and development of gene therapy from the 1950s to the present. It discusses key events like the isolation of genes in the 1970s and 1980s and the first human gene therapy treatment in 1990. It outlines various gene therapy strategies like ex vivo and in vivo approaches and delivery methods like viruses, liposomes, microinjection, and electroporation. Challenges of gene therapy are also summarized like ethical issues, high costs, and ensuring safety. The document aims to provide an overview of the progress of gene therapy and remaining barriers to its clinical application and acceptance.
Socrate
The document outlines a strategy to improve translational research and clinical trials through more tailored and personalized approaches. It proposes combining basic research on topics like DNA repair mechanisms with biology-driven therapies and immunotherapies guided by a patient's specific biomarkers. The goal is to move beyond one-size-fits-all approaches to cancer treatment and instead target therapies based on a patient's individual cancer biology and vulnerabilities to achieve better outcomes.
Solutions for Personalized Medicine brochure
The document discusses personalized medicine and describes some of the tools and technologies used for biomarker discovery and validation to enable personalized medicine. Specifically, it discusses:
1) Affymetrix provides a portfolio of tools to detect and validate DNA and RNA biomarkers for diseases like cancer through microarrays, services, and assays that can interrogate genomes, transcriptomes, genes, pathways, and individual molecules.
2) RNA and DNA biomarkers like gene expressions levels, mutations, and other genomic alterations can serve as indicators of disease processes and therapeutic responses. Affymetrix tools allow analysis of whole genomes, transcriptomes, alternative splicing, and single-cell analysis.
3) These tools are used to discover and validate biomarkers which
Concept of genomics, proteomics and metabolomics
Dr. M. N. Astagimath's presentation discusses genomics, proteomics, and metabolomics. The objectives are to understand the concepts and define each term. Genomics is the study of genomes and involves functional, structural, and epigenomics. Proteomics is the large-scale study of proteins and involves expression, interaction, and biomarker analysis. Metabolomics is the study of small molecule metabolites and their profiles can provide unique fingerprints of cellular processes. A variety of methods are used in each field like sequencing and mass spectrometry. The data has applications in medicine such as diagnosis, risk assessment, and bioengineering.
Genomics
This document summarizes a seminar on genomics presented by Komal Rajgire. It defines genomics as the study of all genes in an organism, including their mapping, sequencing, and functional analysis. The key differences between genetics and genomics are outlined. The document discusses approaches in functional genomics like homology searching and expression analysis. It also covers related fields like structural genomics, epigenomics, metagenomics, pharmacogenomics, and the applications and future impact of genomics on medicine, drug discovery, and personalized treatment.
SCREENING WHAT TESTS WHEN & WHAT NEXT?
This document provides guidance on prenatal screening tests and what they can detect. It discusses the principles of screening and outlines various first and second trimester screening options for detecting chromosomal abnormalities, structural defects, and conditions like preeclampsia. Diagnostic tests mentioned include karyotyping, FISH, QF-PCR, microarrays, and their abilities to identify abnormalities like trisomies, deletions, and duplications. Low-dose aspirin is noted as an intervention for preeclampsia in high-risk patients.
ENT Presentation
This document discusses next generation sequencing to identify bacteria, fungi, and viruses from patient samples. It summarizes discussions and presentations from several ear, nose, and throat doctors and researchers on using DNA sequencing to diagnose biofilm infections. DNA sequencing was able to identify more pathogens than traditional cultures and provided faster results. Identifying biofilms is important as they are resistant to antibiotics and cause chronic infections. The document promotes using a molecular diagnostic test from PathoGenius to identify pathogens in patient samples, which it says provides faster, more comprehensive results than cultures and is covered by Medicare.
Pharmacogenomics
Pharmacogenomics is the study of how genetic factors influence individual responses to drugs. It aims to develop personalized drug therapies tailored to an individual's genetics. This could increase drug effectiveness to nearly 100% while decreasing side effects significantly by identifying genetic reasons for variances in drug response. However, barriers remain such as complexity in finding gene variations and limited drug alternatives. Overall, pharmacogenomics promises more rational drug development and safer, more accurate individualized treatment but overcoming challenges will require multidisciplinary efforts.
Diagnosis of cancer
diagnosis of cancer, bioluminescent detection, diagnosis of cancer, haplotype mapping, imaging gene expression in vivo, types of cancer diagnosis method, ultrasound imaging
Genetic screening & gene therapy
Genetic screening and gene therapy can detect and treat genetic disorders. Genetic screening techniques like carrier screening, newborn screening, and prenatal diagnosis identify genetic risks. Gene therapy aims to treat diseases by replacing faulty genes, such as inserting functional genes into somatic cells. While promising, gene therapy faces challenges like safety concerns over viral vectors and ensuring proper expression of inserted genes. Genetic counseling educates patients on genetic risks and testing options.
Applied Genetic (Genetika Terapan) - Chaidir Adam 2018
Applied Genetic
- Medical Genetic
- DNA Fingerprinting & Forensic Analysis
- PCR, RFLP, Electrophoresis
- Human Genome Project
Genomics
Genomics is the study of genomes, which are the complete set of genetic material within an organism. It has emerged through public funding and collaboration between academic and private research. There are two main eras - the genomic era focused on genome sequencing, while the current post-genomic era analyzes gene functions and regulation. Types of genomics include cognitive, comparative, functional, and personal genomics. It has various applications like drug discovery, conservation efforts, and understanding disease and human variation.
Multi Omics Approach in Medicine
This document discusses multi-omics approaches in medicine. It begins by describing traditional Oslerian and systems approaches to defining disease. It then introduces omics technologies and precision medicine. The main body discusses different omics approaches including genomics, epigenomics, transcriptomics, proteomics, metabolomics, and microbiomics. For each approach, it covers concepts, applications, and challenges. It emphasizes how multi-omics integration can provide a more comprehensive understanding of disease and inform precision medicine.
Gene rx [autosaved]
Gene therapy involves introducing genetic material into cells to treat or prevent disease. It has the potential to cure genetic disorders by correcting the underlying genetic defect. There are two main types - somatic gene therapy, which affects only targeted cells and is safer, and germline gene therapy which can permanently alter the genes and be passed to offspring. Recent advances include FDA-approved CAR-T immunotherapies for cancer and the first gene therapy approved for an inherited retinal disease. Challenges remain regarding delivery methods, safety, and ethical issues.
Similar to GENOMIC & PRECISION MEDICINE (1).pptx (14)
Applied Genetic (Genetika Terapan) - Chaidir Adam 2018
Applied Genetic (Genetika Terapan) - Chaidir Adam 2018
Recently uploaded
Cell Therapy Expansion and Challenges in Autoimmune Disease
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Top-Vitamin-Supplement-Brands-in-India List
Swisschem Dermacare provides the Top 10 Vitamin Supplement Brands in India. To know more about us give us call at our official number
Light House Retreats: Plant Medicine Retreat Europe
Our aim is to organise conscious gatherings and retreats for open and inquisitive minds and souls, with and without the assistance of sacred plants.
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Learn about body grief and ways to cope with it. We will also explore methods to heal from this challenging experience.
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Role of Mukta Pishti in the Management of Hyperthyroidism
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Best Ayurvedic medicine for Gas and Indigestion
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...chandankumarsmartiso
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel With 100% Satisfaction
ABDOMINAL TRAUMA in pediatrics part one.
Abdominal trauma in pediatrics refers to injuries or damage to the abdominal organs in children. It can occur due to various causes such as falls, motor vehicle accidents, sports-related injuries, and physical abuse. Children are more vulnerable to abdominal trauma due to their unique anatomical and physiological characteristics. Signs and symptoms include abdominal pain, tenderness, distension, vomiting, and signs of shock. Diagnosis involves physical examination, imaging studies, and laboratory tests. Management depends on the severity and may involve conservative treatment or surgical intervention. Prevention is crucial in reducing the incidence of abdominal trauma in children.
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
STIs may cause PID. For the both disease, herbal medicine Fuyan Pill can be a solution.
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
It includes regulation of combination products and medical devices. FDA and industry liaisons.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxMGM SCHOOL/COLLEGE OF NURSING
Identification and nursing management of congenital malformations Recently uploaded (20)
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
GENOMIC & PRECISION MEDICINE (1).pptx
- 1. Genomics & Precision Medicine Pelatihan Genomic Researcher IMERI FK UI Dr. Muhammad Taufiq Rahman
- 2. GENOMIC & PRECISION MEDICINE • PENGGUNAAN PROFIL GENETIK UNTUK MEMANDU KEPUTUSAN DALAM TATALAKSANA, PREVENSI,DIAGNOSIS DAN TERAPI PENYAKIT ONE TREATMENT FITS ALL ERA LAMA PERSONALIZED MEDICINE ERA BARU
- 4. GENOM • KESELURUHAN INFORMASI GENETIK DI DALAM TUBUH (THE BOOK OF LIFE) • INTI SEL MATERI GENETIK KROMOSOM (46) • KROSOM GULUNGAN RANTAI PANJANG DNA • DI DALAM DNA TSB BERISI INSTRUKSI UNTUK MEMBUAT PROTEIN
- 6. APA YANG MEMBUAT KITA BERBEDA 99,9 % DNA MANUSIA SAMA 0,1 % WARNA RAMBUT, WARNA KULIT DSB KETIKA DNA DISALIN KETURUNAN BERIKUTNYA NUKLEOTIDA DAPAT BERTAMBAH MAUPUN HILANG PERBEDAAN
- 8. FARMAKOGENOMIK • PENGGUNAAN PROFIL GENETIK SESEORANG DALAM MEMETABOLISME OBAT
- 9. FARMAKOGENOMIK • MEMILIH KOMBINASI OBAT YANG TEPAT • MENCEGAH TERJADINYA RESISTENSI OBAT • BIG DATA
- 10. FARMAKOGENETIK • CYP2C9 METABOLISME SIMVASTATIN • BEBERAPA PERLU PENYESUAIAN DOSIS • CYP2D6 METABOLISME TAMOXIFEN
- 11. ALEXIS DAN NOAH BEERY, MISDIAGNOSED CEREBRAL PALSY SELAMA 14 TAHUN, PADA TAHUN 2010 ORANG TUA MEREKA MELAKUKAN GENETIC SEQUENCING DRD (DOPA- RESPONSIVE DYSTONIA DIOBATI DENGAN L DOPA SEMBUH
- 12. FASILITAS LAB GENOMIC IMERI UI Lab karyotyping
- 13. FASILITAS LAB GENOMIC IMERI UI LAB PCR
- 14. LAB IMUNOLOGY & INFECTIOUS DISEASE
- 16. PRODUCT RISET UI
- 18. PENGEMBANGAN PCR PORTABLE UNTUK RISET GENOMIC GELATO ELECTROPHORESIS. TIDAK MENGGUNAKAN ETHIDIUM BROMIDE, DAN MENGGUNAKAN TEKNOLOGI BLUE LIGHT HARGA 50 JT
- 19. MASUKAN UNTUK INSTITUSI • BAHWA RESEARCH GENOMIC MELIBATKAN BANYAK DISIPLIN ILMU, KEDOKTERAN BERSAMA DENGAN PRODI ATLM, FARMASI DAN GIZI AKAN AKTIF BERKOLABORASI PRODUCT NUTRIGENOMICS PHARMACOGENOMICS PENTINGNYA MENGAPLIKASIKAN ARTIFICIAL INTELEGENCE DALAM PROSES PEMBELAJARAN
- 20. 3 PILAR PENGEMBANGAN KEDOKTERAN UNIVERSITY BASED HOSPITALITY BASED RESEARCH CENTER